CNST
Income statement / Annual
Last year (2020), Constellation Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Constellation Pharmaceuticals, Inc.'s net income was -$126.36 M.
See Constellation Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$95.50 M
|
$66.46 M
|
$48.77 M
|
$32.62 M
|
$27.88 M
|
| General & Administrative
Expenses |
$29.35 M
|
$19.60 M
|
$12.48 M
|
$6.47 M
|
$5.78 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$29.35 M
|
$19.60 M
|
$12.48 M
|
$6.47 M
|
$5.78 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$124.85 M |
$86.06 M |
$61.24 M |
$39.09 M |
$33.66 M |
| Cost And Expenses |
$124.85 M |
$86.06 M |
$61.24 M |
$39.09 M |
$33.66 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$2.86 M |
$2.12 M |
$228,000.00 |
$901,000.00 |
$1.35 M |
| Depreciation &
Amortization |
$644,000.00
|
$758,000.00
|
$562,000.00
|
$474,000.00
|
$203,000.00
|
| EBITDA |
-$122.81 M
|
-$82.65 M
|
-$59.14 M
|
-$34.00 M
|
-$32.99 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$1.47 M
|
$529,000.00
|
$1.32 M
|
$3.71 M
|
-$875,000.00
|
| Income Before Tax |
-$126.32 M |
-$85.53 M |
-$59.93 M |
-$35.38 M |
-$34.53 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$39,000.00 |
$24,000.00 |
$1.55 M |
$4.61 M |
$470,000.00 |
| Net Income |
-$126.36 M |
-$85.55 M |
-$59.93 M |
-$35.38 M |
-$34.53 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-4.49 |
-3.04 |
-5 |
-3.03 |
-0.72 |
| EPS Diluted |
-4.49 |
-3.04 |
-5 |
-3.03 |
-0.72 |
| Weighted Average Shares
Out |
$28.15 M
|
$28.15 M
|
$11.98 M
|
$11.69 M
|
$47.97 M
|
| Weighted Average Shares
Out Diluted |
$28.15 M
|
$28.15 M
|
$11.98 M
|
$11.69 M
|
$47.97 M
|
| Link |
|
|
|
|
|
